IP Verse

Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes

Patent No. EP3294333 (titled "Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes") was filed by Biontech Cell&Gene Therapies on May 9, 2016. The application was issued on Jul 9, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR H ULRICH DORRIESMay 31, 2021DORRIES
DR H ULRICH DORRIESMay 31, 2021DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3294333

BIONTECH CELL&GENE THERAPIES
Application Number
EP16721176A
Filing Date
May 9, 2016
Status
Patent Maintained As Amended
Feb 14, 2025
Publication Date
Jul 9, 2025
External Links
Slate, EP3294333B9, Google Patents